Nektar Therapeutics said on Tuesday its lead drug candidate met the main goal of a mid-stage study testing the drug in eczema patients, sending its shares up by nearly 140%. In the 393-patient global ...

In the midst of a drug epidemic fueled by meth and fentanyl that has brought chaos to the area, the Downtown has became ...

The trial resumed Tuesday, June 24, with Teny Geragos, one of Combs' attorneys, continuing her cross examination of Joseph ...

The new facility will relieve $1.5 million in initial recurring funds to support its first year, with plans for continued ...

A new study published in The American Journal of Drug and Alcohol Abuse found that 11.7% of adults entering New York City ...